Poster Presentation ESA-SRB-ANZBMS 2024 in conjunction with ENSA

Exploring associations between aldosterone and bone health (#362)

Stella M Gwini 1 , Kara Holloway-Kew 2 , Lana Williams 2 , Jun Yang 1 , Julie Pasco 2
  1. Hudson Institute of Medical Research, Clayton, VIC, Australia
  2. IMPACT – the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia
Publish consent withheld
  1. 1. Turcu, A.F., J. Yang, and A. Vaidya, Primary aldosteronism—a multidimensional syndrome. Nature Reviews Endocrinology, 2022. 18(11): p. 665-682.
  2. 2. Libianto, R., et al., Detecting primary aldosteronism in Australian primary care: a prospective study. Medical Journal of Australia, 2022. 216(8): p. 408-412.
  3. 3. Käyser, S.C., et al., Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis. The Journal of Clinical Endocrinology & Metabolism, 2016. 101(7): p. 2826-2835.
  4. 4. Vaidya, A., J.M. Brown, and J.S. Williams, The renin–angiotensin–aldosterone system and calcium-regulatory hormones. Journal of human hypertension, 2015. 29(9): p. 515-521.
  5. 5. Pasco, J.A., G.C. Nicholson, and M.A. Kotowicz, Cohort Profile: Geelong Osteoporosis Study. International Journal of Epidemiology, 2011. 41(6): p. 1565-1575.